Arellano ML, Thirman MJ, DiPersio JF, Heiblig M, et al. Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study. Blood 2025 May 7:blood.2025028357. doi: 10.1182/blood.2025028357.
PMID: 40332046